Schitzophrenia Flashcards
Classification of schizophrenia
- DSM 5 = one positive and at two negative symptoms of schizophrenia
- ICD-10= Two or more negative symptoms of schizophrenia
Positive symptoms
additional experiences beyond those ordinary existence
- hallucinations= either have no basis in reality or distorted perceptions of things that are not there
- delusions= have no basis in reality
- grandeur= believe they are an important historical figure e.g. Jesus
- persecution= e.g. the government
-of the body= suffered may feel there body is under external control
- of thoughts
- speech disorganisation= speech is incoherent or speaker changes topic mid sentence
Negative symptoms
Loss of usual abilities and experience s
-avolition= finding it difficult to begin or keep up with either goal- directed activity due to lack of motivation. E.g. poor hygiene, work/education
-speech poverty= reduction is the amount of speech. Often accompanied by a delay in the suffers verbal response during a conversation.
Evaluation of schizophrenia to do with reliability
-low-inter reliability= the extent to which two or more mental health professionals arrive at the same diagnosis for the same patient. Cheniaux et al (2009) has two psychiatrist diagnose 100 patients using both DSM and ICD criteria. One psychiatrist diagnosing 26 with schizophrenia according to DSM and 44 according to ICD, the other 13 according to DSM and 24 according to ICD.
ALSO has poor validity= different assessment systems arrive at the same diagnosis. Using cheniaux et al study is seen schizophrenia is more likely to be diagnosed using the ICD than DSM. So may be over-diagnosed in ICD or under-diagnosed in DSM.
Biological explanations for schizophrenia ( the genetic bias)
Gottesman (1991) found that as genetic similarity increases so does the probability of sharing schizophrenia. E.g. first cousins has a 2%, DZ 17% chance whereas identical twins have 48%.
-schizophrenia is found to be polygenic because different studies have identified different candidate genes.
- Stephen Ripke et al (2014) carried out a study combining all previous data from genome-wide studies of schizophrenia. The genetic makeup of 370000 patients was compared to that of 113000 controls, 108 separate genetic variation were associated with risk of schizophrenia which included those coding for the functioning of a number of neurotransmitters including dopamine .
Evidence for the biological explanation of schizophrenia ( genetic bias)
-gottesman (1991) shows how genetic similarity and shared rush of schizophrenia are closely related.
-Tiernari et al (2004) adoption study shows that children of schizophrenia suffered are still at heightened risk of schizophrenia if adopted into families with no history of schizophrenia.
-Ripke et al (2014) found that particular genetic variations significantly increases the risk of developing schizophrenia.
psychological explanations-schizophrenic mother
–Fromm-reichm noted that many of her patients spoke of a particular type of parent in which she called the schizophrenic mother which is cold,rejecting and controlling and tend to create a family climate characterized by tension and secrecy. this tend to leads to distrust that later develops into paranoid delusions, and ultimately schizophrenia
psychological explanations- cognitive explanations
- Frith et al identified two types of dysfunctional thought processing that could underlie symptoms
-metarepresentation= leads to the inability to recognize our own actions and thoughts as
being carried out by ourselves rather than someone else. this would explain hallucinations of voices and delusions
-central control= the cognitive ability to suppress automatic responses while we perform deliberate actions. the inability could result in disorganised speech and though disorder.,g, schizophrenic suffers tend to experience derailment of thoughts and spoken sentences each word triggers a new associations, and patient cannot suppress automatic responses to theses
evaluation of psychological explanations to do with evidence
there is a lot of evidence:
-Read et al reviewed fourty six studies of child abuse and schizophrenia and concluded that 69% of adult women with a diagnosis experience abuse being physical,sexual or both in childhood. men had 59%/
-adults with an insecure attachment were also more likely to develop schizophrenia.
-HOWEVER, most of this evidence was gathered after the patient already showed symptoms of schizophrenia so recall of their childhood may have been distorted lowering the validly. Tienari et al followed up children following childhood experiences to see if they predicted any adult characteristics. There is prospective evidence linking family dysfunction to schizophrenia but not a huge amount
biological therapies for treating schizophrenia=drug therapies
- chlorpromazine= 50s. initally dosages are smaller for most patients but it gradually builds upulot by binding to blocking dopamine receptors in the synapse of the brain, reducing the action of dopamine which in tern normalizes transmission in key areas of the brain, reducing symptoms like schizophrenia
Typical( first generation)
-clozapine=60s.used when other treatments failed and patients have to take regular blood test to ensure they are not developing agranulocytosis.. Binds to receptors in the same way as chlorpromazine but alos serotonin and glutamate receptors. the action helps improve mood and reduce depression and anxiety in patients and may improve cognitive functioning. it is sometimes prescribed to patients at risk of suicide which is common in people suffering.
-risperidone= 90s. binds to dopamine and serotonin receptors but binds more strongly to dopamine receptors than clozapine so is therefore effective in smaller doses. there is some evidence to suggest that this leads to fewer side effects.
ATYPICAL (after typical drugs), 50s)
Evaluation of biological therapies( drug therapies) evidence,side effects
-lots of evidence to support effectiveness for atypical and typical antipsychotics.
-Thornley et al (2003) reviewed studies comparing the effects of chlorpromazine to control conditions in which patients received a placebo.
Typical =Data from 13 trials with a total of 1121 participants showed that chlorpromazine was associated with overall better functioning and reduced symptoms of severity. Data from 3 trials with a total of 512 participants showed that relapse rate was also lower when chlorpromazine was taken.
Atypical = Melzer (2012) concluded that clozapine is more effective than typical antipsychotics and other atypical antipsychotics and in 30-50% of treatment-resistant cases where typical antipsychotics failed.
- despite evidence , Healy(2012) has suggested that some successful trials have had their data published multiple times, exaggerating the evidence for positive effects. Also because they have a calming effect, it is easy to that they have some positive effect on patients which is not the same as saying they reduce severity of psychosis. AND most published studies access short-term benefits and not long term.
- serious side effects. Typical antipsychotics= dizziness,agitation,sleepiness,stiff jaw,weight gain and itchy skin. Long term use can result in tardive dyskinesia which is caused by dopamine hypersensitivity manifesting in involuntary face movements such as blinking or lip smacking. Neuroleptic malignant syndrome (NMS) is the most serious side effect. Caused by the drug blocking dopamine action in the hypothalamus. This results in high temperature, delirium and coma which can be fatal.
- although Atypical drug were developed to reduce side effects they still exist. E.g. patients taking clozapine have regular blood tests
- depend if the dopamine hypothesis= evidence shows that the the original dopamine hypothesis such as…. Is not a complete explanation of schizophrenia and dopamine levels are in other parts of the brain are too low rather than too high. If true then it’s not clear how antipsychotic, which are dopamine antagonists can help with schizophrenia when they reduce dopamine activity. Modern understanding suggests antipsychotic shouldn’t work therefore this has undermined the faith of some people that they do work
Psychological therapies
- CBT =aim involves helping patients identify irrational thoughts and trying to change them.
-usually takes place between 5 and twenty sessions.
-may involve arguments or a discussion of how likely the patients beliefs are to be true, and a consideration of other less threatening possibilities. can help patients be able to cope with symptoms better
-family therapy=aims to improve the quality of communication and interaction between family members. Nowdays most family therapy are more concerned with reducing stress within the family that might contribute to the patients risk of relapse.
-pharoah et al (two thousand and ten) identified a range of stratergies by which work by reducing levels of stress and expressed emotion whilst increasing the chances increasing the chance of patients complying with their medication.combination of benefits result in the reduced likelihood of relapse and re admission to hospitals
-token economies= reward systems used to manage the behavior of patients with schizophrenia, in particular those who have developed maladaptive behavior through being institutionalised in psychiatric hospitals. patients under these condition tend to develop bad habits such as bad hygeine so modifying theses bad habitats may improve the patients quality of life and make it more likely they can live outside a hospital setting. Tokens are given to patients once they perform a desirable behaviour such as getting dressed or making the bed as reinforcement.
- although the tokens have no value itself they can be swapped later for more tangible rewards e.g. sweets, cigarettes etc..
- based on operant conditioning in which the tokens are secondary reinforcers as they only have value once the patient has learned they can obtain a reward.
evaluation of pyschological therapies
- Limitation is there is only modest support for the effectiveness of psychological treatments,
-jauahr et al (Fourteen) reviewed the result of CBT for schizophrenia. they concluded that CBT has a significant but fairly small effect on both positive and negative symptoms.
Pharoah et al. reviewed the evidence for the effectiveness of family therapy for families of schizophrenia sufferers. They concluded that there is moderate evidence to show that family therapy significantly reduces hospital readmission over the course of a year and improves quality of life for patients and their families. However, they also noted that results of different studies were inconsistent and that there were problems with the quality of some evidence. Overall then the evidence base for family therapy is fairly weak. - - - (McMonagle and Sultana 2009) who studied evidence for Token economy found only three studies where patients had been randomly allocated to conditions, with a total of only 110 patients. Random allocation is important in matching patients to treatment and control groups. Only one of the three studies showed improvement in symptoms and none yielded useful information about behaviour change.
- All the psychological treatments for schizophrenia aim to make schizophrenia more manageable and in some way improve patients’ quality of life. CBT helps by allowing patients to make sense of and in some cases challenge some of their symptoms. Family therapy helps by reducing the stress of living with schizophrenia in a family, both for the patient themselves and other family members. Token economies help by making patients’ behaviour more socially acceptable so that they can better re-integrate into society. These things are all worth doing, but should not be confused with curing schizophrenia. Of course biological treatments do not cure schizophrenia either but they do reduce the severity of some symptoms.
This failure to cure schizophrenia is a weakness of psychological treatments. - Talk about maybe drug therapies therefore being more effective and a study that shows this*
Although psychological treatments for schizophrenia do not have the serious side effects or medical risks of drug treatments, they can raise ethical issues. In particular token economy systems have proved controversial. The major issue is that privileges, services, etc., become more available to patients with mild symptoms and less so for those with more severe symptoms of schizophrenia that prevent them complying with desirable behaviours.
This means that the most severely ill patients suffer discrimination in addition to other symptoms, and some families of patients have challenged the legality of this. This has in turn reduced the use of token economies in the psychiatric system.
Other psychological therapies can raise additional issues. CBT may involve, for example, challenging a person’s paranoia, but at what point does this interfere with an individual’s freedom of thought? If, for example, CBT challenged a patient’s beliefs in a highly controlling government, this can easily stray into modifying their politics.
Ethical issues like this are a weakness of psychological treatments for schizophrenia.
- link to issues and debates free will
- also There are other psychological therapies that can be helpful for some people with schizophrenia that are less well-known and less likely to be available to patients.
For example, the National Institute for Health and Clinical Excellence (NICE) recommends art therapy, provided a qualified art therapist with experience of working with schizophrenia sufferers is available. May have less ethical issues
The interactionist approach - original diathesis- stress model
The diathesis-stress model says that both a vulnerability to schizophrenia and a stress-trigger are necessary in order to develop the condition
- In the original diathesis-stress model (Meehl 1962) diathesis (vulnerability) was entirely genetic, the result of a single ‘schizogene’. This led to the development of a biologically based schizotypic personality. According to Paul Meehl, if a person does not have the schizogene then no amount of stress would lead to schizophrenia. However, in carriers of the gene, chronic stress through childhood and adolescence, in particular the presence of a schizophrenogenic mother could result in the development of the condition.
Evidence of the interactionist approach
- there is evidence to support the dual role of vulnerability and stress in the development of schizophrenia.Tienari et al. (2004) investigated the combination of genetic vulnerability and parenting style (the trigger). Children adopted from 19,000 Finnish mothers with schizophrenia between 1960 and 1979 were followed up. Their adoptive parents were assessed for child-rearing style, and the rates of schizophrenia were compared to those in a control group of adoptees without any genetic risk. A child-rearing style characterised by high levels of criticism and conflict and low levels of empathy was implicated in the development of schizophrenia but only for the children with high genetic risk but not in the control group. This suggests that both genetic vulnerability and family-related stress are important in the development of schizophrenia. Which supports the model